Cargando…
Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
SIMPLE SUMMARY: Non-muscle invasive bladder cancer (NMIBC) requires frequent cystoscopies for follow-up, which can be costly and uncomfortable for patients. This study aimed to assess the accuracy of Uromonitor, a non-invasive urinary test, in detecting NMIBC recurrence and reducing the number of cy...
Autores principales: | Azawi, Nessn, Vásquez, Juan Luis, Dreyer, Thomas, Guldhammer, Cathrine Silberg, Saber Al-Juboori, Rami Muthanna, Nielsen, Anna Munk, Jensen, Jørgen Bjerggaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137147/ https://www.ncbi.nlm.nih.gov/pubmed/37190269 http://dx.doi.org/10.3390/cancers15082341 |
Ejemplares similares
-
Intraoperative Mitomycin C Bladder Instillation During Radical Nephroureterectomy Is Feasible and Safe
por: Nadler, Naomi, et al.
Publicado: (2021) -
Locus solus /
por: Roussel, Raymond, 1877-1933
Publicado: (2003) -
Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
por: Sieverink, Caroline A., et al.
Publicado: (2020) -
Red patches during bladder cancer surveillance: to biopsy or not to biopsy?
por: Drejer, Ditte, et al.
Publicado: (2018) -
GRade, Age, Nodes, and Tumor (GRANT) compared with Leibovich score to predict survival in localized renal cell carcinoma: A nationwide study
por: Juul, Simon, et al.
Publicado: (2022)